Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND)
Today, Bank of America raised its price target on Ascendis Pharma A/S (NASDAQ:ASND) to $60.00 per share.
Some recent analyst ratings include
- 1/19/2018-HC Wainwright Reiterated Rating of Buy.
- 1/17/2018-JPMorgan Chase & Co. Reiterated Rating of Buy.
- 9/22/2017-Wells Fargo & Co Reiterated Rating of Buy.
- 9/22/2017-Credit Suisse Group Reiterated Rating of Outperform.
- 9/22/2017-Wedbush Reiterated Rating of Outperform.
- 9/1/2017-Leerink Swann Reiterated Rating of Hold.
Recent Trading Activity for Ascendis Pharma A/S (NASDAQ:ASND)
Shares of Ascendis Pharma A/S closed the previous trading session at 54.54 up +0.37 0.68% with shares trading hands.